ASX shares to buy for the next decade
Bubs Australia Ltd (ASX: BUB)
At the moment Bubs is my favourite small cap ASX share idea. The company is displaying all of the right attributes to generate strong returns over the next decade.
For a long-term idea I like to see a large potential total addressable market that the company is only just beginning to tap. The infant formula ASX share is growing in China, Vietnam and I’m sure it has it’s aiming for other Asian countries with consumers that want high-quality products. In 10 years we may see Bubs sold in places like North America or even Europe.
I also want to see that the company is growing its profit margin. Economies of scale is another factor for delivering strong profit growth. In the FY20 half-year result the company saw its gross margin increase from 19% to 24%. In June 2018 the gross margin was just 14%.
The other factor I like to see is effective leadership. Bubs has done a really good job of expanding its domestic and international distribution channels as well as securing its supply chain, particularly with the Deloraine manufacturing facility acquisition.
I’d like to buy shares at the current Bubs share price.
---------------------------------------------------------------------------------------------------------------------------
Exciting small cap ASX share to buy
Bubs
Goat milk producer Bubs has established a very strong position in the Australian market. It has become Australia’s only vertically integrated producer of goat milk formula, and has been a star performer in terms of revenue growth throughout the coronavirus pandemic.
Bubs delivered a massive 67% increase in revenue to $19.7 million during Q3 FY20 to 31 March 2020, compared to the prior corresponding period. In addition, sales have now pleasingly risen to a point where Bubs is generating positive operating cashflow. This is a significant milestone for a small cap ASX share.
Bubs has now shifted its focus to the massive Asian market – a strategy that is already starting to see results. The company’s Chinese revenues soared 104% higher in the third quarter of FY 2020. Infant formula scandals in China have seen a preference for Australian made products, due to the perception of higher safety and higher quality. In addition, the rising demand for Chinese e-commerce platforms such as JD.com and Alibaba’s TMall is enabling a large and growing number of buyers and sellers to connect with each other.
I believe that Bubs’ Asian growth strategy positions the company well for strong growth over the next 2 to 3 years.
BUB
bubs australia limited
Add to My Watchlist
5.56%
!
17.0¢

BUB chart, page-2446
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $151.8M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.0¢ | $170.5K | 979.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 716290 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 97636 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 645650 | 0.170 |
7 | 369412 | 0.165 |
14 | 400986 | 0.160 |
23 | 1360110 | 0.155 |
23 | 1338487 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 47636 | 5 |
0.180 | 912370 | 19 |
0.185 | 226700 | 6 |
0.190 | 481314 | 13 |
0.195 | 322491 | 6 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online